Write in a clean editor, then format for JCSM Clinical Reports in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
JCSM Clinical Reports is a peer-reviewed journal published by Wiley, covering Nutrition and Health in Aging, Frailty in Older Adults, Body Composition Measurement Techniques.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." JCSM Clinical Reports 12 (3): 45–58.
Formats any DOI in JCSM Clinical Reports style. No sign-up. |
| Publishes research in | Nutrition and Health in Aging Frailty in Older Adults Body Composition Measurement Techniques Diverse Scientific and Economic Studies Human auditory perception and evaluation |
| ISSN | 2521-3555 |
| h-index | 15 |
| i10-index | 24 |
| Total citations | 913 |
| Article processing charge | $1,875 |
| Open access | Yes |
| Top institutions publishing here | Monash University |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Abstract Background Sarcopenic dysphagia is characterized by difficulty swallowing due to loss of whole‐body skeletal and swallowing muscle mass and function. Despite multiple reports regarding sarcopenic dysphagia, no verified diagnostic methods exist. The purpose of this study was to develop a diagnostic algorithm for sarcopenic dysphagia and verify its reliability and validity. Methods First, our…
Progressive skeletal muscle wasting in cancer cachexia involves a process of dysregulated protein synthesis and breakdown. This catabolism may be the result of mal-nutrition, and an upregulation of both pro-inflammatory cytokines and the ubiquitin proteasome pathway (UPP), which can subsequently increase myostatin and activin A release. The skeletal muscle wasting associated with cancer cachexia is…
Abstract Myostatin, a member of the transforming growth factor beta (TGF‐β) superfamily that is highly expressed in skeletal muscle, was first described in 1997. It has been known that loss of myostatin function induces an increase in muscle mass in mice, cow, dogs and humans. Therefore, myostatin and its receptor have emerged as a therapeutic…
Abstract Aims Sarcopenia has recently been given an ICD‐10 code. However, there have been no systematic investigations regarding the prevalence or prognostic value of sarcopenia in cardiovascular disease (CVD) according to the international consensus definition. The present study was performed to investigate the prevalence and prognostic value of sarcopenia in elderly patients with CVD. Methods…
Abstract Background Myostatin (MSTN) is a key negative regulator of muscle mass in humans and animals, having direct and indirect influences on molecular regulators of atrophy and hypertrophy, thus potentially impacting fitness and physical function. We have shown that myostatin is elevated in conditions of chronic disability (e.g. paretic limb of stroke). Our hypothesis is…
